Tumor angiogenesis: causes, consequences, challenges and opportunities
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor angiogenesis: causes, consequences, challenges and opportunities
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-06
DOI
10.1007/s00018-019-03351-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Vessel co-option in cancer
- (2019) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- VEGF in Signaling and Disease: Beyond Discovery and Development
- (2019) Rajendra S. Apte et al. CELL
- Targeting APLN/APLNR improves anti-angiogenic efficiency and blunts pro-invasive side effects of VEGFA/VEGFR2-blockade in glioblastoma
- (2019) Giorgia Mastrella et al. CANCER RESEARCH
- Apelin and apelin receptor expression in renal cell carcinoma
- (2019) Yuri Tolkach et al. BRITISH JOURNAL OF CANCER
- EphB4 mediates resistance to antiangiogenic therapy in experimental glioma
- (2018) Christian Uhl et al. ANGIOGENESIS
- Consensus guidelines for the use and interpretation of angiogenesis assays
- (2018) Patrycja Nowak-Sliwinska et al. ANGIOGENESIS
- Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment
- (2018) Qi Zhao et al. CANCER RESEARCH
- Tumor stroma–targeted antibody-drug conjugate triggers localized anticancer drug release
- (2018) Christopher Szot et al. JOURNAL OF CLINICAL INVESTIGATION
- CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
- (2018) Roberta Lugano et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules
- (2018) Bo He et al. JOURNAL OF PATHOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
- (2018) Sara A Hurvitz et al. LANCET ONCOLOGY
- Nogo-B promotes tumor angiogenesis and provides a potential therapeutic target in hepatocellular carcinoma
- (2018) Hao Cai et al. Molecular Oncology
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- (2018) Kabir A. Khan et al. Nature Reviews Clinical Oncology
- IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas
- (2018) Lei Zhang et al. NEURO-ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
- (2018) Joao Incio et al. Science Translational Medicine
- The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer
- (2018) Marta B. Wysocka et al. Frontiers in Physiology
- Targeting VEGF/VEGFR to Modulate Antitumor Immunity
- (2018) Ju Yang et al. Frontiers in Immunology
- Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
- (2018) Adriana Albini et al. Frontiers in Immunology
- Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma
- (2018) Thomas Powles et al. BRITISH JOURNAL OF CANCER
- Insights into Endothelial Progenitor Cells: Origin, Classification, Potentials, and Prospects
- (2018) H. Chopra et al. Stem Cells International
- Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
- (2018) Maria Georganaki et al. Frontiers in Immunology
- Neutrophils as active regulators of the immune system in the tumor microenvironment
- (2017) Merav E. Shaul et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
- (2017) ShaghayeghHaghjooy Javanmard et al. Journal of Research in Medical Sciences
- Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
- (2017) Krishnansu S Tewari et al. LANCET
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Marianne E Pavel et al. LANCET ONCOLOGY
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Miguel Martin et al. LANCET ONCOLOGY
- Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium
- (2017) Federico Galvagni et al. MATRIX BIOLOGY
- FGF-dependent metabolic control of vascular development
- (2017) Pengchun Yu et al. NATURE
- Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging
- (2017) Xin Mei et al. NEURO-ONCOLOGY
- New Directions in Anti-Angiogenic Therapy for Glioblastoma
- (2017) Nancy Wang et al. Neurotherapeutics
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface
- (2017) K A Khan et al. ONCOGENE
- Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
- (2017) Arman Jahangiri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
- (2017) Kartik Angara et al. Translational Oncology
- Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
- (2017) Helen Ha et al. Theranostics
- Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Promotes Tumor Destruction
- (2017) Emily J. Colbeck et al. Cancer Immunology Research
- Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma
- (2017) Bo Zhu et al. NEOPLASIA
- Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer
- (2016) Meiyan Feng et al. BMC CANCER
- Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype
- (2016) Timothy N. Phoenix et al. CANCER CELL
- Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers
- (2016) Florence T.H. Wu et al. CANCER RESEARCH
- Endosialin-Expressing Pericytes Promote Metastatic Dissemination
- (2016) Carmen Viski et al. CANCER RESEARCH
- PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13
- (2016) Deguan Lv et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
- (2016) Naoki Horikawa et al. CLINICAL CANCER RESEARCH
- Cell behaviors and dynamics during angiogenesis
- (2016) Charles Betz et al. DEVELOPMENT
- FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal
- (2016) Monika Haemmerle et al. JOURNAL OF CLINICAL INVESTIGATION
- Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma
- (2016) Elizabeth A. Kuczynski et al. JNCI-Journal of the National Cancer Institute
- Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
- (2016) Teresa E. Peterson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
- (2016) Jonas Kloepper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Sunitinib: the antiangiogenic effects and beyond
- (2016) Zhonglin Hao et al. OncoTargets and Therapy
- Vasculogenic mimicry in small cell lung cancer
- (2016) Stuart C. Williamson et al. Nature Communications
- Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism
- (2016) Yunlong Yang et al. Nature Communications
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
- (2016) Maria Serova et al. Oncotarget
- Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment
- (2016) Luuk van Hooren et al. Oncotarget
- EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
- (2016) Benjamin Krusche et al. eLife
- Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma
- (2016) Elizabeth A. Kuczynski et al. JNCI-Journal of the National Cancer Institute
- Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies
- (2016) Antonia Reale et al. Stem Cells International
- CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice
- (2016) Xuguang Chen et al. PLoS One
- Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival
- (2015) Elise Langenkamp et al. CANCER RESEARCH
- Chemokines as effector and target molecules in vascular biology
- (2015) Silvano Sozzani et al. CARDIOVASCULAR RESEARCH
- Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage
- (2015) C. Mogler et al. EMBO Molecular Medicine
- VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation
- (2015) Hua Huang et al. FASEB JOURNAL
- Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma
- (2015) Zorica Špirić et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Hypoxia-inducible factor 1 and breast cancer metastasis
- (2015) Zhao-ji Liu et al. Journal of Zhejiang University-SCIENCE B
- Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
- (2015) Nick Thatcher et al. LANCET ONCOLOGY
- Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Jin Li et al. LANCET ONCOLOGY
- Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas
- (2015) Lei Zhang et al. Science Signaling
- Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy
- (2015) Francesco Moccia et al. TUMOR BIOLOGY
- Intratumoral Myeloid Cells Regulate Responsiveness and Resistance to Antiangiogenic Therapy
- (2015) Lee B. Rivera et al. Cell Reports
- CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
- (2015) Eunyoung Chun et al. Cell Reports
- Endothelial Cell Self-fusion during Vascular Pruning
- (2015) Anna Lenard et al. PLOS BIOLOGY
- Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas
- (2015) Lei Zhang et al. Science Signaling
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
- (2015) Svetlana Karakhanova et al. OncoImmunology
- Neoplastic cells are a rare component in human glioblastoma microvasculature
- (2015) Fausto J. Rodriguez et al. Oncotarget
- Apelin promotes lymphangiogenesis and lymph node metastasis
- (2015) Judit Berta et al. Oncotarget
- Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer
- (2015) Julia Femel et al. Oncotarget
- Activation of Urokinase Plasminogen Activator and Its Receptor Axis Is Essential for Macrophage Infiltration in a Prostate Cancer Mouse Model
- (2015) Jian Zhang et al. NEOPLASIA
- The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
- (2015) Antonino Bruno et al. NEOPLASIA
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Therapeutic vaccination targeting the tumour vasculature: Figure 1
- (2014) Anna-Karin Olsson BIOCHEMICAL SOCIETY TRANSACTIONS
- Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
- (2014) Edward B Garon et al. LANCET
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
- (2014) Luca Gianni et al. LANCET ONCOLOGY
- Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study
- (2014) Timothy J Price et al. LANCET ONCOLOGY
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
- (2013) A. K. Fielding et al. BLOOD
- NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis
- (2013) A. Fantin et al. BLOOD
- A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis
- (2013) Massimo Masiero et al. CANCER CELL
- Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
- (2013) Lin Cheng et al. CELL
- Filopodia are dispensable for endothelial tip cell guidance
- (2013) Li-Kun Phng et al. DEVELOPMENT
- In Vivo Analysis Reveals a Highly Stereotypic Morphogenetic Pathway of Vascular Anastomosis
- (2013) Anna Lenard et al. DEVELOPMENTAL CELL
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
- (2013) Josep Tabernero et al. EUROPEAN JOURNAL OF CANCER
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma WithEGFRMutations
- (2013) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- VEGFA and tumour angiogenesis
- (2013) L. Claesson-Welsh et al. JOURNAL OF INTERNAL MEDICINE
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis
- (2013) Chunmei Yang et al. PLoS One
- Blood Flow Changes Coincide with Cellular Rearrangements during Blood Vessel Pruning in Zebrafish Embryos
- (2013) Eva Kochhan et al. PLoS One
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- On the cytokines produced by human neutrophils in tumors
- (2013) Cristina Tecchio et al. SEMINARS IN CANCER BIOLOGY
- Vascular Permeability and Drug Delivery in Cancers
- (2013) Sandy Azzi et al. Frontiers in Oncology
- Tumor Cell Vasculogenic Mimicry
- (2012) Richard E.B. Seftor et al. AMERICAN JOURNAL OF PATHOLOGY
- Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression
- (2012) Hua Zhou et al. ANGIOGENESIS
- Semaphorin 6A regulates angiogenesis by modulating VEGF signaling
- (2012) M. Segarra et al. BLOOD
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
- (2012) Monika Julia Wolf et al. CANCER CELL
- TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types
- (2012) Amit Chaudhary et al. CANCER CELL
- T-Cell Trafficking Facilitated by High Endothelial Venules Is Required for Tumor Control after Regulatory T-Cell Depletion
- (2012) J. P. Hindley et al. CANCER RESEARCH
- Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A-Induced Angiogenesis
- (2012) F. Roudnicky et al. CANCER RESEARCH
- Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization
- (2012) Lothar C Dieterich et al. JOURNAL OF PATHOLOGY
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
- (2012) Winette TA van der Graaf et al. LANCET
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) George D Demetri et al. LANCET
- First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
- (2012) Siow Ming Lee et al. LANCET ONCOLOGY
- Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
- (2012) Aimery de Gramont et al. LANCET ONCOLOGY
- Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs
- (2012) Zhanlong Shen et al. MEDICAL ONCOLOGY
- Antiangiogenic therapy—evolving view based on clinical trial results
- (2012) Gordon C. Jayson et al. Nature Reviews Clinical Oncology
- Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
- (2012) Y. Piao et al. NEURO-ONCOLOGY
- Hypoxia-induced up-regulation of apelin is associated with a poor prognosis in oral squamous cell carcinoma patients
- (2012) Kyun Heo et al. ORAL ONCOLOGY
- Tumor-targeted TNF stabilizes tumor vessels and enhances active immunotherapy
- (2012) A. Johansson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression
- (2011) M. Franco et al. BLOOD
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- Discovery of a Competitive Apelin Receptor (APJ) Antagonist
- (2011) N. J. Maximilian Macaluso et al. ChemMedChem
- Distinct Cellular Mechanisms of Blood Vessel Fusion in the Zebrafish Embryo
- (2011) Lukas Herwig et al. CURRENT BIOLOGY
- Prognostic Role of Vasculogenic Mimicry in Colorectal Cancer
- (2011) Coen I. M. Baeten et al. DISEASES OF THE COLON & RECTUM
- Tumor exploits alternative strategies to achieve vascularization
- (2011) Benedetta Bussolati et al. FASEB JOURNAL
- HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells
- (2011) Giuseppina Comito et al. FREE RADICAL BIOLOGY AND MEDICINE
- TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice
- (2011) Abigail F. Welford et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
- (2011) Hideaki Ijichi et al. JOURNAL OF CLINICAL INVESTIGATION
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells
- (2011) Sandra M. Blois et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and angiogenic role of the novel tumor endothelial marker CLEC14A
- (2011) M Mura et al. ONCOGENE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Forty-Year Journey of Angiogenesis Translational Research
- (2011) Y. Cao et al. Science Translational Medicine
- Vascular mimicry in cultured head and neck tumour cell lines
- (2011) Tahwinder Upile et al. Head and Neck Optical Diagnostics Society
- Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching
- (2010) G. A. Strasser et al. BLOOD
- Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro
- (2010) Yaodong Zhao et al. BRAIN RESEARCH BULLETIN
- FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
- (2010) Pauline Andreu et al. CANCER CELL
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking
- (2010) Haruko Hayasaka et al. CANCER SCIENCE
- PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
- (2010) Carlos Bais et al. CELL
- CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
- (2010) G. Yang et al. CLINICAL CANCER RESEARCH
- Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas
- (2010) S.-S. Chae et al. CLINICAL CANCER RESEARCH
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity
- (2010) Alberto Mantovani et al. CURRENT OPINION IN IMMUNOLOGY
- Vaccination against the extra domain-B of fibronectin as a novel tumor therapy
- (2010) Elisabeth J. M. Huijbers et al. FASEB JOURNAL
- IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
- (2010) V. Gocheva et al. GENES & DEVELOPMENT
- Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas
- (2010) Jeffrey P. Greenfield et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
- (2010) Xiaoyuan Huang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients
- (2010) Olivier Adotevi et al. JOURNAL OF IMMUNOTHERAPY
- Apelin Expression in Human Non-small Cell Lung Cancer: Role in Angiogenesis and Prognosis
- (2010) Judit Berta et al. Journal of Thoracic Oncology
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
- (2010) Suphansa Sawamiphak et al. NATURE
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
- (2010) Yingdi Wang et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting
- (2010) Lars Jakobsson et al. NATURE CELL BIOLOGY
- VEGFRs and Notch: a dynamic collaboration in vascular patterning: Figure 1
- (2009) Lars Jakobsson et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients
- (2009) Joong Bae Ahn et al. CANCER LETTERS
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
- (2009) H. Xin et al. CANCER RESEARCH
- Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
- (2009) Massimiliano Mazzone et al. CELL
- Intussusceptive microvascular growth in human glioma
- (2009) Beatrice Nico et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- Nrarp Coordinates Endothelial Notch and Wnt Signaling to Control Vessel Density in Angiogenesis
- (2009) Li-Kun Phng et al. DEVELOPMENTAL CELL
- Adiponectin promotes migration activities of endothelial progenitor cells via Cdc42/Rac1
- (2009) Nobuhisa Nakamura et al. FEBS LETTERS
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- ELR-CXC Chemokine Receptor Antagonism Targets Inflammatory Responses at Multiple Levels
- (2009) X. Zhao et al. JOURNAL OF IMMUNOLOGY
- Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
- (2009) Ronald P DeMatteo et al. LANCET
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma
- (2009) Man Li et al. PATHOLOGY & ONCOLOGY RESEARCH
- Reticulon 4B (Nogo-B) is necessary for macrophage infiltration and tissue repair
- (2009) J. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors
- (2009) Ayesha B. Alvero et al. STEM CELLS
- Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells
- (2008) Sven Christian et al. AMERICAN JOURNAL OF PATHOLOGY
- Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis
- (2008) H. Chen et al. BLOOD
- TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype
- (2008) R. C. A. Sainson et al. BLOOD
- Complex cell rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo
- (2008) Yannick Blum et al. DEVELOPMENTAL BIOLOGY
- CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex
- (2008) Daniel Martin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endothelial cell differentiation of human breast tumour stem/progenitor cells
- (2008) Benedetta Bussolati et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice
- (2008) Juliana Hamzah et al. JOURNAL OF CLINICAL INVESTIGATION
- Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
- (2008) Maciej Kujawski et al. JOURNAL OF CLINICAL INVESTIGATION
- Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2
- (2008) Yvonne Reiss et al. JOURNAL OF PATHOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- (2008) Edward S Kim et al. LANCET
- Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis
- (2008) Yingchun Dong et al. MODERN PATHOLOGY
- Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
- (2008) Tuomas Tammela et al. NATURE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
- (2007) V. W.M. van Hinsbergh et al. CARDIOVASCULAR RESEARCH
- The role of chemokines in neutrophil biology
- (2007) Yoshiro Kobayashi Frontiers in Bioscience-Landmark
- Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells
- (2007) Laura S. Harrington et al. MICROVASCULAR RESEARCH
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More